Gotham Asset Management’s Eton Pharmaceutcials ETON Stock Holding History

Gotham Asset Management’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$579K	Buy	+15,982	New	+$469K	﹤0.01%	1482

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Gotham Asset Management's ETON Position: Q2 2026 in Review

Gotham Asset Management opened a new position in Eton Pharmaceutcials (ETON) in Q2 2026: 15,982 shares worth $579K. The stake represents ﹤0.01% of the portfolio and ranks #1482 among its holdings.

165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Gotham Asset Management held 15,982 shares of Eton Pharmaceutcials worth $579K as of Q2 2026.
Eton Pharmaceutcials was a new Gotham Asset Management position in Q2 2026.
Eton Pharmaceutcials made up ﹤0.01% of Gotham Asset Management's portfolio in Q2 2026, its #1482 holding.
165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.